Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M. Westers, Arjan A. van de Loosdrecht, Eline M.P. Cremers et al.|Haematologica|2016Cited by 100
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.Ilse Schwarzinger, Peter Bettelheim, Peter Valent et al.|Journal of Clinical Oncology|1990Cited by 96
Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLC. Marosi, Oskar A. Haas, Ursula Köller et al.|Cancer Genetics and Cytogenetics|1992Cited by 74
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A. van de Loosdrecht, Marie C. Béné, Robin Ireland et al.|Leukemia & lymphoma/Leukemia and lymphoma|2012Cited by 69
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issuesAnna Porwit, Arjan A. van de Loosdrecht, Marie C. Béné et al.|Cytometry Part B Clinical Cytometry|2022Cited by 50